Cytodyn Inc (CYDY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 05/31
| 05-2010 | 05-2009 | 05-2008 | 05-2007 | 05-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 701 | 266 | 85 | 17 | 125 |
| Other current assets | 1,824 | 0 | 0 | 0 | 0 |
| TOTAL | $2,544 | $273 | $137 | $110 | $429 |
| Non-Current Assets | |||||
| PPE Net | 4 | 2 | 1 | 3 | 2 |
| Intangibles | 0 | 0 | 1 | 1 | 1 |
| Other Non-Current Assets | 24 | 30 | 37 | 1 | 1 |
| TOTAL | $28 | $32 | $39 | $4 | $4 |
| Total Assets | $2,572 | $305 | $176 | $114 | $432 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 154 | N/A | N/A | N/A | 393 |
| Accounts payable and accrued liabilities | 205 | 350 | 433 | 250 | 116 |
| Accrued Expenses | 1,195 | 49 | 25 | 194 | 134 |
| Other current liabilities | 3,997 | 25 | 50 | N/A | 76 |
| TOTAL | $5,551 | $492 | $508 | $568 | $742 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 262 | 718 | 456 | N/A |
| Other Non-Current Liabilities | 236 | 251 | 276 | 14 | 0 |
| TOTAL | $236 | $513 | $993 | $620 | $N/A |
| Total Liabilities | $5,787 | $1,005 | $1,501 | $1,189 | $742 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 20,942 | 19,891 | 18,951 | 11,297 | 11,225 |
| Common Shares | 7,145 | 6,286 | 4,469 | 4,173 | 3,063 |
| Retained earnings | -13,241 | -10,148 | -8,575 | -7,381 | -4,207 |
| Other shareholders' equity | -2,137 | 167 | 0 | -107 | 0 |
| TOTAL | $-3,216 | $-700 | $-1,325 | $-1,074 | $-309 |
| Total Liabilities And Equity | $2,572 | $305 | $176 | $114 | $432 |